Otsuka Holdings
4578.T
#774
Rank
โ‚น2.874 T
Marketcap
โ‚น5,442
Share price
-0.12%
Change (1 day)
23.21%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2025 (TTM): โ‚น258.54

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น280.72. In 2024 the company made an earnings per share (EPS) of โ‚น368.38 an increase over its 2023 EPS that were of โ‚น145.09.

EPS history for Otsuka Holdings from 2009 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น258.54-29.82%
2024โ‚น368.38153.9%
2023โ‚น145.09-15.71%
2022โ‚น172.13-6.18%
2021โ‚น183.46-24.1%
2020โ‚น241.7222.95%
2019โ‚น196.5956.13%
2018โ‚น125.92-25.11%
2017โ‚น168.1525.99%
2016โ‚น133.47-6.37%
2015โ‚น142.55
2014N/A-100%
2013โ‚น214.7818.06%
2012โ‚น181.921.01%
2011โ‚น180.0929.07%
2010โ‚น139.53-94.47%
2009โ‚น2,523